What is the latest status of the project “Lilly Weight-Loss Drug Manufacturing Plant”?

The status recorded for “Lilly Weight-Loss Drug Manufacturing Plant” is planned.

What is the budget and commercial profile for the project “Lilly Weight-Loss Drug Manufacturing Plant”?

Taiyo normalizes the budget of “Lilly Weight-Loss Drug Manufacturing Plant” to USD 6000000000.

Where can I verify the source and access all details for “Lilly Weight-Loss Drug Manufacturing Plant”?

This Taiyo project page references Manufacturing Dive along with the original URL (https://www.manufacturingdive.com/news/lilly-build-6b-weight-loss-drug-factory-huntsville-alabama/807628/). Taiyo standardizes official data into a consistent, searchable project profile.

Lilly Weight-Loss Drug Manufacturing Plant

Sector: Manufacturing (Industrial) • Location: Huntsville, Alabama, United States

Source: Manufacturing Dive

Project

Planned

Eli Lilly plans to invest over $6 billion to build a manufacturing plant in Huntsville, Alabama, focused on weight loss medications and other pharmaceutical ingredients. The site will manufacture orforglipron, Lilly's first oral, small molecule GLP-1 receptor agonist. The factory is expected to bring 450 jobs and construction is set to begin next year, generating 3,000 jobs related to the project.

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Huntsville, Alabama, United States of America
Updated: 22 Jul 2026
Source: Manufacturing Dive

ConstructChat

Ask ConstructChat about Lilly Weight-Loss Drug Manufacturing Plant

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “Lilly Weight-Loss Drug Manufacturing Plant” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Huntsville, Alabama, United States. Taiyo aggregates data on it from Manufacturing Dive.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Eli Lilly plans to invest over $6 billion to build a manufacturing plant in Huntsville, Alabama, focused on weight loss medications and other pharmaceutical ingredients. The site will manufacture orforglipron, Lilly's first oral, small molecule GLP-1 receptor agonist. The factory is expected to bring 450 jobs and construction is set to begin next year, generating 3,000 jobs related to the project.
Original sector	Pharmaceutical Manufacturing
Budget

Location

Country	United States of America (USA)
State	Alabama
City	Huntsville

Source

Source	Manufacturing Dive
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-12-14

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Lilly Weight-Loss Drug Manufacturing Plant

Ask ConstructChat about Lilly Weight-Loss Drug Manufacturing Plant

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States